Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a minimally-invasive, palliative procedure designed for patients whose cancer has metastasized and is unresponsive to conventional ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the FDA. Detailed results were announced from a phase 3 clinical trial evaluating the ...

Eli Lilly's tirzepatide cut cardiovascular mortality and heart failure event risk by 38% in HFpEF patients over a two-year ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...

Radiation therapy (RT) is a cornerstone in cancer treatment, known for its ability to induce tumor cell death and modulate ...

The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.

An E. coli outbreak that has sickened dozens of people and caused one death is tied to bagged, organic baby carrots sold ...